摘要
胰腺癌是恶性程度极高的消化系统肿瘤,其症状隐匿、治疗手段有限、进展迅速。随着胰腺癌的发病率逐年上升,胰腺癌越来越成为危害公共健康的突出问题,造成了巨大的社会负担。尽管胰腺癌患者的生存率在最近20余年并无明显改善,但目前在胰腺癌领域中,流行病学、基础和临床研究明显加速,有些研究成果已使一小部分胰腺癌患者取得更好的生存获益。本文就2023年度胰腺癌研究及诊疗的重大进展进行综述。
Pancreatic cancer is a highly malignant digestive tract tumor with hidden symptoms,limited treatment options and rapid progression.With an increasing incidence rate year by year,pancreatic cancer has increasingly become a prominent issue endangering public health,causing a huge social burden.Although there was no significant improvement in survival rates for pancreatic cancer patients in the past two decades,recent progress in epidemiology,basic research and clinical research of pancreatic cancer has accelerated significantly compared to the past.Some findings have already enabled a small proportion of pancreatic cancer patients to achieve better survival.This article provided a review of the significant progress made in research,diagnosis and treatment of pancreatic cancer in 2023.
作者
李天骄
叶龙云
金凯舟
吴伟顶
虞先濬
LI Tianjiao;YE Longyun;JIN Kaizhou;WU Weiding;YU Xianjun(Department of Pancreatic Surgery,Fudan University Shanghai Cancer Center,Department of Oncology,Shanghai Medical College,Fudan University,Pancreatic Cancer Institute,Fudan University,Shanghai Pancreatic Cancer Institute,Shanghai 200032,China)
出处
《中国癌症杂志》
CAS
CSCD
北大核心
2024年第1期1-12,共12页
China Oncology
基金
国家自然科学基金(U21A20374,82173091)。
关键词
胰腺癌
流行病学
基础研究
临床研究
Pancreatic cancer
Epidemiology
Basic research
Clinical research
